Xeris Pharmaceuticals, Inc. · 4 hours ago
Senior Financial Analyst
Chicago, IL
Full-time
Hybrid
Mid, Senior Level
$75K/yr - $100K/yr
3+ years expXeris Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing innovative therapies. The Senior Financial Analyst will provide financial support and analysis related to inventory management, manufacturing expense, and product cost, acting as a key business partner to various operational teams.
BiotechnologyDiabetesHealth CarePharmaceuticalTherapeutics
Responsibilities
Lead the annual budgeting and quarterly forecasting processes across commercial and lifecycle management manufacturing teams
Prepare and update detailed expense templates and forecasts; consolidate departmental inputs for review
Collaborate with FP&A leadership to ensure all financial assumptions are accurate and consistent with company objectives
Present financial data to all levels of the organization to highlight important drivers and metrics
Support cash balance projection process through calculation of cash flow impacts related to procurement and production of commercial products
Support quarterly and annual COGS forecasting processes for commercial products
Develop and maintain cost models to project product gross margins under various volume and pricing scenarios
Analyze actual vs. forecasted manufacturing costs, including material, labor, and overhead variances
Provide insights into COGS trends and drivers for management and investor reporting
Partner with Accounting to lead standard cost setting process leveraging information contained in supplier contracts and production forecasts
Collaborate with Supply Chain and Technical Operations to track and forecast inventory levels across raw materials, WIP, and finished goods
Monitor inventory obsolescence, write-offs, and production yields, providing timely financial impact assessments, including proactive tracking and communication of risks and opportunities
Support monthly close activities by reconciling inventory balances and COGS entries with Accounting and prepare analysis on key variance drivers
Help develop and refine inventory reporting tools to improve visibility and accuracy
Act as a financial partner to Supply Chain, Manufacturing, and Quality functions
Support budgeting and expense tracking for internal manufacturing and external contract manufacturing organizations (CMOs)
Assist with financial evaluations of supply agreements, purchase requests, production decisions, and capacity planning initiatives
Support the FP&A team in maintaining accurate COGS and inventory components within the corporate financial model
Contribute to process improvements to increase forecasting efficiency and reporting quality, including supporting FP&A system implementation and maintenance
Qualification
Required
Bachelor's Degree in Finance, Accounting, Supply Chain Management or a related field
3-5 years of experience in FP&A or corporate finance, ideally within pharmaceuticals, biotech, life sciences, or manufacturing
Advanced Excel and financial modeling skills
Familiarity with FP&A systems
Strong analytical, organization, presentation and communication skills
Ability to manage multiple priorities and meet deadlines in a fast-paced environment
Competencies: Methodical, Detail-oriented, Interpersonal skills, Written and Verbal Communication skills, Strategic, Professionalism, Organizational skills, Self-directed, Teamwork, Adaptability
Position may require periodic evening and weekend work, as necessary to fulfill obligations
Periodic overnight travel
This is a hybrid role based in Xeris' Chicago office and requires a minimum of three days per week in the office
Benefits
Bonus
Equity
Multiple paid time off benefits
Various health insurance options
Retirement benefits
Company
Xeris Pharmaceuticals, Inc.
We're a growth-oriented biopharmaceutical company improving patient lives by developing and commercializing advanced products across a range of therapies.
201-500 employees
Funding
Current Stage
Public CompanyTotal Funding
$548.5MKey Investors
Hayfin Capital ManagementArmistice CapitalDeerfield
2024-03-06Post Ipo Debt· $200M
2022-01-03Post Ipo Equity· $30M
2021-03-11Post Ipo Equity· $27M
Leadership Team
John Shannon
CEO and Director
Kenneth Johnson
Senior Vice President - Clinical Development, Regulatory Affairs, QA and Medical Affairs
Recent News
2026-01-09
The Motley Fool
2026-01-03
Company data provided by crunchbase